TITLE:
      A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)
SUMMARY:
      This is a study to evaluate the safety and tolerability of Caelyx used for the treatment of
      metastatic breast cancer (MBC), focusing on infusion reaction and palmar-plantar
      erythrodysesthesia (PPE).
DETAILED DESCRIPTION:
      Patients selected by investigator according to clinical routine
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Patients with metastatic breast cancer

        Exclusion Criteria:

          -  History of hypersensitivity to Caelyx or its components

          -  Women who are pregnant or breast-feeding

          -  Patients with severe myelosuppression
